Your session is about to expire
← Back to Search
Hydraderm for Male Pattern Baldness
Study Summary
This trial will study the effects of a hydradermabrasion treatment on the scalp. The goal is to see if it improves scalp health and hair growth.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on immunosuppressive therapy.I have a bleeding or clotting disorder.I have been diagnosed with a blood disorder.I am between 18 and 65 years old and in good health.I agree to not change my current hair loss treatment during the study.I understand the study, can follow instructions, and will attend all required visits.I am positive for HIV, Hepatitis B, or Hepatitis C.I have an active skin infection or inflammation in the area to be treated.I have had a skin biopsy or procedure on my scalp in the last month.You have been diagnosed with an autoimmune disease.You have a current severe skin allergy.I have had skin cancer on my scalp before.I do not have scalp conditions like eczema, psoriasis, infections, or scars in the treatment area.You have male or female pattern baldness.I am currently receiving chemotherapy.I haven't changed my hair loss treatment in the last 4 months.You have a medical device implanted near the area where the treatment will be given.I am using birth control or am unable to have children due to menopause or surgery.I agree to not change my current hair loss treatment during the study.
- Group 1: Treatment
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being monitored in this research project?
"Affirmative. According to clinicaltrials.gov, this experiment has been open for recruitment since March 14th 2022 and was recently updated on June 20th 2022. The research is enrolling 40 participants from a single medical setting."
Are there any active openings for participants to join this research?
"According to the clinicaltrials.gov database, this research programme is still accepting participants; it was first made available on March 14th 2022 and has received a recent update as of June 20th 2022."
Will persons younger than 80 years be considered for involvement in this research?
"The criteria for enrollment into this clinical trial includes a minimum age of 18 and an upper limit of 65."
Are there any health risks associated with using Venus Glow?
"Evidence from the Phase 4 trial demonstrates that Venus Glow is safe, thereby assigning it a score of 3."
Who would be most suitable to enroll in this medical experiment?
"This clinical trial seeks 40 adults (18-65 years) who suffer from alopecia and meet the following criteria: comprehension of study guidelines, voluntary provision of written consent including HIPAA compliance, current treatment for alopecia with no plans to change it during the course of the trial, agreement to be photographed without concealment for research purposes, commitment to use one specific shampoo throughout the duration."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger